<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/290ee" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/290ee/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/290ee/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_290ee"><akn:num>290ee</akn:num><akn:heading>Opioid overdose reversal medication access, education, and co-prescribing grant programs</akn:heading><akn:content><akn:p>§ 290ee. Opioid overdose reversal medication access, education, and co-prescribing grant programs(a) GrantsThe Secretary shall make grants to States, localities, Indian Tribes, and Tribal organizations (as those terms are defined in section 5304 of title 25) to—(1) implement strategies that increase access to drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] for emergency treatment of known or suspected opioid overdose, as appropriate, pursuant to a standing order;

(2) encourage pharmacies to dispense opioid overdose reversal medication pursuant to a standing order;

(3) encourage health care providers to co-prescribe, as appropriate, drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose;

(4) develop or provide training materials that persons authorized to prescribe or dispense a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose may use to educate the public concerning—(A) when and how to safely administer such drug or device; and

(B) steps to be taken after administering such drug or device; and


(5) educate the public concerning the availability of drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose without a person-specific prescription.


(b) Certain requirementA grant may be made under this section only if the State involved has authorized standing orders to be issued for drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose.


(c) Preference in making grantsIn making grants under this section</akn:p></akn:content><akn:subsection eId="subsec_290ee_a"><akn:num>(a)</akn:num><akn:heading>Grants</akn:heading><akn:content><akn:p>(a) Grants The Secretary shall make grants to States, localities, Indian Tribes, and Tribal organizations (as those terms are defined in section 5304 of title 25) to—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_b"><akn:num>(b)</akn:num><akn:heading>Certain requirement</akn:heading><akn:content><akn:p>(b) Certain requirement A grant may be made under this section only if the State involved has authorized standing orders to be issued for drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_c"><akn:num>(c)</akn:num><akn:heading>Preference in making grants</akn:heading><akn:content><akn:p>(c) Preference in making grants In making grants under this section, the Secretary may give preference to States that have a significantly higher rate of opioid overdoses than the national average, and that—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_d"><akn:num>(d)</akn:num><akn:heading>Grant terms</akn:heading><akn:content><akn:p>(d) Grant terms</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_e"><akn:num>(e)</akn:num><akn:heading>Applications</akn:heading><akn:content><akn:p>(e) Applications To be eligible to receive a grant under this section, a State shall submit an application to the Secretary in such form and manner and containing such information as the Secretary may reasonably require, including detailed proposed expenditures of grant funds.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_f"><akn:num>(f)</akn:num><akn:heading>Reporting</akn:heading><akn:content><akn:p>(f) Reporting A State that receives a grant under this section shall, at least annually for the duration of the grant, submit a report to the Secretary evaluating the progress of the activities supported through the grant. Such reports shall include information on the number of pharmacies in the State that dispense a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose under a standing order, and other information as the Secretary determines appropriate to evaluate the use of grant funds.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_g"><akn:num>(g)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(g) Definitions In this section the term “standing order” means a document prepared by a person authorized to prescribe medication that permits another person to acquire, dispense, or administer medication without a person-specific prescription.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_h"><akn:num>(h)</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>(h) Authorization of appropriations</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>